[1]
“Management of post-menopausal osteoporosis in leprosy patients using one-monthly oral Ibandronate administration”, Int Jour of Biomed Res, vol. 8, no. 11, pp. 623–629, Nov. 2017, doi: 10.7439/ijbr.v8i11.4468.